Suchergebnisse - "Zambelli, Alberto"

PubPharm (171)

1

Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer : clinical trials, current impact, and future directions

enthalten in: Critical reviews in oncology/hematology | 2024

von Gerosa, R. | De Sanctis, R. | Jacobs, F. | +10

2

Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer : An Expert Consensus on Open Issues for Future Research

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Conforti, F. | Pala, L. | De Pas, T. | +13

3

Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer

enthalten in: Biomedicines | 2024

von Saltalamacchia, G. | Torrisi, R. | De Sanctis, R. | +8

4

Real-world use of multigene signatures in early breast cancer : differences to clinical trials

enthalten in: Breast cancer research and treatment | 2024

von Licata, L. | De Sanctis, R. | Vingiani, A. | +15

5

The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant Chemotherapy

enthalten in: Cancers | 2024

von Tinterri, C. | Fernandes, B. | Zambelli, A. | +8

6

Common Misconceptions about Diet and Breast Cancer : An Unclear Issue to Dispel

enthalten in: Cancers | 2024

von Lalioti, A. | Verzeletti, L. | Tiberio, P. | +7

7

Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade : Results of the GIM 13-AMBRA Study

enthalten in: Cancers | 2023

von Cazzaniga, M. | Pronzato, P. | Amoroso, D. | +39

8

Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer : Analysis of four prospective studies

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Miglietta, F. | Dieci, M. | Giarratano, T. | +18

9

Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016)

enthalten in: Journal for immunotherapy of cancer | 2023

von Pellegrino, B. | Tommasi, C. | Serra, O. | +21

10

A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Zambelli, A. | Cazzaniga, M. | La Verde, N. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]